The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine

Overview

Journal Curr Top Med Chem

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2024 Feb 27

PMID 38409730

Authors

Kalpesh Mahajan

Sankha Bhattacharya

Affiliations

Soon will be listed here.

Abstract

Nanocarriers have emerged as a promising class of nanoscale materials in the fields of drug delivery and biomedical applications. Their unique properties, such as high surface area- tovolume ratios and enhanced permeability and retention effects, enable targeted delivery of therapeutic agents to specific tissues or cells. However, the inherent instability of nanocarriers poses significant challenges to their successful application. This review highlights the importance of nanocarrier stability in biomedical applications and its impact on biocompatibility, targeted drug delivery, long shelf life, drug delivery performance, therapeutic efficacy, reduced side effects, prolonged circulation time, and targeted delivery. Enhancing nanocarrier stability requires careful design, engineering, and optimization of physical and chemical parameters. Various strategies and cutting-edge techniques employed to improve nanocarrier stability are explored, with a focus on their applications in drug delivery. By understanding the advances and challenges in nanocarrier stability, this review aims to contribute to the development and implementation of nanocarrier- based therapies in clinical settings, advancing the field of nanomedicine.

Citing Articles

SynBioNanoDesign: pioneering targeted drug delivery with engineered nanomaterials.

Cai Q, Guo R, Chen D, Deng Z, Gao J J Nanobiotechnology. 2025; 23(1):178.

PMID: 40050980 PMC: 11884119. DOI: 10.1186/s12951-025-03254-9.

Evaluation of the In-Vitro Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules against Protoscolices of Hydatid Cyst.

Soleymani N, Sadr S, Santucciu C, Rahdar A, Masala G, Borji H Pathogens. 2024; 13(9).

PMID: 39338980 PMC: 11435210. DOI: 10.3390/pathogens13090790.

References

Patra J, Das G, Fraceto L, Campos E, Del Pilar Rodriguez-Torres M, Acosta-Torres L . Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018; 16(1):71. PMC: 6145203. DOI: 10.1186/s12951-018-0392-8. View

Muringayil Joseph T, Mahapatra D, Esmaeili A, Piszczyk L, Hasanin M, Kattali M . Nanoparticles: Taking a Unique Position in Medicine. Nanomaterials (Basel). 2023; 13(3). PMC: 9920911. DOI: 10.3390/nano13030574. View

Dong X . Current Strategies for Brain Drug Delivery. Theranostics. 2018; 8(6):1481-1493. PMC: 5858162. DOI: 10.7150/thno.21254. View

Blanco E, Shen H, Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015; 33(9):941-51. PMC: 4978509. DOI: 10.1038/nbt.3330. View

Mitchell M, Billingsley M, Haley R, Wechsler M, Peppas N, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2020; 20(2):101-124. PMC: 7717100. DOI: 10.1038/s41573-020-0090-8. View

Su S, Kang P . Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems. Pharmaceutics. 2020; 12(9). PMC: 7559885. DOI: 10.3390/pharmaceutics12090837. View

Younis N, Ghoubaira J, Bassil E, Tantawi H, Eid A . Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine. 2021; 36:102433. DOI: 10.1016/j.nano.2021.102433. View

Dang B, Kwon T, Lee S, Jeong J, Yook S . Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy. J Control Release. 2023; 365:773-800. DOI: 10.1016/j.jconrel.2023.12.007. View

Gurunathan S, Thangaraj P, Wang L, Cao Q, Kim J . Nanovaccines: An effective therapeutic approach for cancer therapy. Biomed Pharmacother. 2023; 170:115992. DOI: 10.1016/j.biopha.2023.115992. View

10.

Shi L, Liu X, Zhou L, Zhu Z, Yuan Q, Zou T . Nanocarriers for gene delivery to the cardiovascular system. Biomater Sci. 2023; 11(24):7709-7729. DOI: 10.1039/d3bm01275a. View

11.

Afzal O, Altamimi A, Nadeem M, Alzarea S, Almalki W, Tariq A . Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials (Basel). 2022; 12(24). PMC: 9781272. DOI: 10.3390/nano12244494. View

12.

Ahlawat J, Guillama Barroso G, Masoudi Asil S, Alvarado M, Armendariz I, Bernal J . Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood-Brain Barrier: Challenges and Possibilities. ACS Omega. 2020; 5(22):12583-12595. PMC: 7288355. DOI: 10.1021/acsomega.0c01592. View

13.

Alshawwa S, Kassem A, Farid R, Mostafa S, Labib G . Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence. Pharmaceutics. 2022; 14(4). PMC: 9026217. DOI: 10.3390/pharmaceutics14040883. View

14.

Mazayen Z, Ghoneim A, Elbatanony R, Basalious E, Bendas E . Pharmaceutical nanotechnology: from the bench to the market. Futur J Pharm Sci. 2022; 8(1):12. PMC: 8760885. DOI: 10.1186/s43094-022-00400-0. View

15.

Navya P, Kaphle A, Srinivas S, Bhargava S, Rotello V, Daima H . Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg. 2019; 6(1):23. PMC: 6626766. DOI: 10.1186/s40580-019-0193-2. View

16.

Adabi M, Naghibzadeh M, Adabi M, Zarrinfard M, Esnaashari S, Seifalian A . Biocompatibility and nanostructured materials: applications in nanomedicine. Artif Cells Nanomed Biotechnol. 2016; 45(4):833-842. DOI: 10.1080/21691401.2016.1178134. View

17.

Guerrini L, Alvarez-Puebla R, Pazos-Perez N . Surface Modifications of Nanoparticles for Stability in Biological Fluids. Materials (Basel). 2018; 11(7). PMC: 6073273. DOI: 10.3390/ma11071154. View

18.

Gelperina S, Kisich K, Iseman M, Heifets L . The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005; 172(12):1487-90. PMC: 2718451. DOI: 10.1164/rccm.200504-613PP. View

19.

Wu L, Zhang J, Watanabe W . Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011; 63(6):456-69. DOI: 10.1016/j.addr.2011.02.001. View

20.

Yusuf A, Almotairy A, Henidi H, Alshehri O, Aldughaim M . Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles' Physicochemical Properties on Responses in Biological Systems. Polymers (Basel). 2023; 15(7). PMC: 10096782. DOI: 10.3390/polym15071596. View